Table 1.
Clinical characteristic of TLE patients
| Number | Age (Y) | Sex (M/F) | Course (Y) | AEDs before surgery | Resection tissue |
|---|---|---|---|---|---|
| 1 | 23 | M | 4 | VPA, TPM, PHT | TNl |
| 2 | 32 | M | 6 | VPA, CBZ, OXC | TNr |
| 3 | 24 | M | 17 | PB, PHT, TPM | TNr |
| 4 | 31 | F | 12 | CBZ, VPA, TPM | TNr |
| 5 | 45 | M | 10 | TPM, LTG, CBZ | TNl |
| 6 | 30 | M | 18 | VPA, TPM, GBP | TNl |
| 7 | 17 | F | 6 | VPA, TPM, CBZ | TNl |
| 8 | 38 | M | 11 | CBZ, TPM, LTG, PHT | TNr |
| 9 | 29 | F | 12 | VPA, TPM, OXC | TNl |
| 10 | 47 | F | 14 | VPA, PB, LTG, PHT | TNr |
| 11 | 36 | F | 16 | TPM, LTG, CBZ, OXC | TNl |
| 12 | 22 | M | 7 | VPA, CBZ, LTG | TNl |
AEDs, antiepileptic drugs (taken before operation); CBZ, carbamazepine; F, female; GBP, gabapentin; LTG, lamotrigine; l, left; M, male; OXC, oxcarbazepine; PB, phenobarbital; PHT, phenytoin; r, right; TN, temporal neocortex; TPM, topamax; VPA, valproic acid; y, year.